Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NCBMJ open

Adverse oral effects of GLP-1 and GIP receptor agonists: a scoping review protocol.

  • Doménica Gabriela Escudero Samaniego1
  • Melany Abigail Falconí Tarapués1
  • Bianca Taíz Cañarte Vergara1
  • Manuella Salm Coelho2
  • Maria de Fátima De Magalhães Gonzaga3
  • Cristine Miron Stefani4
  • Thais Marques Simek Gonçalves5
  • Graziela De Luca Canto2,6
  • Patricia Pauletto7
7 affiliations
  1. 1Faculty of Dentistry, Universidad de Las Americas Facultad de Ciencias de la Salud, Quito, Ecuador.
  2. 2Brazilian Centre for Evidence-Based Research, Federal University of Santa Catarina, Florianópolis, Brazil.
  3. 3University Hospital of Brasilia, University of Brasília, Brasília, Brazil.
  4. 4Department of Dentistry, University of Brasilia, Brasília, Brazil.
  5. 5Department of Dentistry, Federal University of Santa Catarina, Florianópolis, Brazil.
  6. 6Department of Medicine, Federal University of Sao Paulo, São Paulo, Brazil.
  7. 7Faculty of Dentistry, Universidad de Las Americas Facultad de Ciencias de la Salud, Quito, Ecuador [email protected].
Read full textPDFDOICite

Related

  1. GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
    Shi-ping Sun, Yan Fang, Li Liu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity
    Hilal Şimşek, Aslı Uçar
    Current Nutrition ReportsPeer-reviewedCC BY12 citedPhysiologyOpenAlex
  3. Reproductive and Gynecologic Effects of Glucagon-Like Peptide-1 Receptor Agonists in Women With Polycystic Ovary Syndrome: A Scoping Review.
    Jacklyn Snytte, Brielle Hazan, Amanda Weissman +1
    CureusPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
  4. Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database
    Burak Ogulcan Yildirim, Ibrahim Furkan Sarkim, Gizem Yalman +3
    BMC Cardiovascular DisordersPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyPMCDOAJ
  5. Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
    Audrey Y. Chang, Farrah J. Mateen
    Annals of clinical and translational neurologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{samaniego2026adverse,
  title = {{Adverse oral effects of GLP-1 and GIP receptor agonists: a scoping review protocol.}},
  author = {Doménica Gabriela Escudero Samaniego and Melany Abigail Falconí Tarapués and Bianca Taíz Cañarte Vergara and Manuella Salm Coelho and Maria de Fátima De Magalhães Gonzaga and Cristine Miron Stefani and Thais Marques Simek Gonçalves and Graziela De Luca Canto and Patricia Pauletto},
  journal = {BMJ open},
  year = {2026},
  month = oct,
  doi = {10.1136/bmjopen-2026-122207},
  url = {https://europepmc.org/article/MED/42901597},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Adverse oral effects of GLP-1 and GIP receptor agonists: a scoping review protocol.
AU  - Doménica Gabriela Escudero Samaniego
AU  - Melany Abigail Falconí Tarapués
AU  - Bianca Taíz Cañarte Vergara
AU  - Manuella Salm Coelho
AU  - Maria de Fátima De Magalhães Gonzaga
AU  - Cristine Miron Stefani
AU  - Thais Marques Simek Gonçalves
AU  - Graziela De Luca Canto
AU  - Patricia Pauletto
PY  - 2026
DA  - 2026/10/20
JO  - BMJ open
DO  - 10.1136/bmjopen-2026-122207
UR  - https://europepmc.org/article/MED/42901597
SN  - 2044-6055
ER  -